COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,625 Articles (22,913 medRxiv, 8,712 bioRxiv)

Most recent first Previous |  Page 123: Articles 1221-1230  | Next

Development of pyrazolopyrimidine based macrocyclic kinase inhibitors targeting AAK1
Mensing, T. E., Kurz, C. G., Amrhein, J. A., Ehret, T. A. L., Preuss, F., Mathea, S., Karim, M., Tran, D. H. N., Kadlecova, Z., Tolvanen, T., Martinez-Molina, D., Mueller, S., Einav, S., Knapp, S., Hanke, T.
10.1101/2025.04.02.646796 — Posted: 2025-04-03
Genetic diversity of pangolin coronaviruses reveals a key immuno-evasive substitution at spike residue 519
Yo, M. S., Kaku, Y., Kosugi, Y., Tolentino, J. E., Cao, y. R., Sato, K.
10.1101/2025.04.01.646621 — Posted: 2025-04-02
Single-chain permuted proteins for dimerization-based control of protein activity and cellular processes
Zeleznik Ramuta, T., Snoj, J., Kos, T., Ljubetic, A., Hafner-Bratkovic, I., Jerala, R.
10.1101/2025.03.31.645681 — Posted: 2025-04-02
Pre-Clinical Evaluation of a Novel Immunomodulator: a potential immunotherapy for coronaviral disease
Lee, I., Desai, A., Berdis, A. J., Patil, A., Xu, Y., Pozza-Adams, K.
10.1101/2025.04.01.646433 — Posted: 2025-04-02
Implementation of culturally responsive communication for racial, ethnic, sexual, and gender minoritized patients when screened for COVID-19 vaccinations: A scoping review
Kalita, N., Corr, P. G., Ward, M. C., Xavier, J., McDonald, P. L.
10.1101/2025.03.30.25324915 — Posted: 2025-04-01
A sensitive multiplex RT-qPCR assay to detect SARS-CoV-2 in respiratory samples
Halliday, A., Morales-Aza, B., Duale, K., Bristol Vaccine Centre Microbiology and Molecular Laboratories, , Lait, P., Milligan, R., Hutchings, S., Pymont, H., Vipond, B., Muir, P., Waterfall, C., Coghill, J., Carr, J., Plested, E., Oliver, J., Fidler, K., Relton, C., Snape, M. D., Be On The Team Investigators, , Davidson, A. D., Helps, C., Finn, A.
10.1101/2025.03.31.25323652 — Posted: 2025-04-01
The effect of SARS-CoV-2 testing on healthcare seeking behaviour at primary care level: implications for COVID-19 vaccine effectiveness estimates in test-negative design studies.
van Hagen, C. C. E., Vos, E. R. A., Laniece Delaunay, C., de Melker, H. E., Kissling, E., Knol, M. J.
10.1101/2025.03.31.25324928 — Posted: 2025-04-01
Effectiveness of COVID-19 vaccine booster doses in adults aged 50 years and over during the Omicron period in Victoria, Australia
Szanyi, J., Yang, Y., Zeng, J., Clarke, C., Buttery, A. K., Blakely, T.
10.1101/2025.03.31.25324986 — Posted: 2025-04-01
The development and usability testing of six arts-based knowledge translation tools for parents about COVID-19
Scott, S. D., Elliott, S. A., Reid, K., Knisley, L., Hartling, L.
10.1101/2025.03.31.25324968 — Posted: 2025-04-01
Ketamine inhibition of SARS-CoV-2 replication in astrocytes is associated with COVID-19 disease severity in a variant-dependent manner
Furlani, B., Potokar, M., Korva, M., Resman Rus, K., Pozvek, P., Zorec, T. M., Vrsnik, J., Pirnat, S., Tavcar Verdev, P., Smolic, T., Horvat, A., Radinovic, K., Graselli Kmet, N., Avsic-Zupanc, T., Vardjan, N., Stenovec, M., Jereb, M., Jorgacevski, J., Zorec, R.
10.1101/2025.03.29.646083 — Posted: 2025-04-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).